— Know what they know.
Not Investment Advice

LFCR NASDAQ

Lifecore Biomedical, Inc.
1W: +55.7% 1M: +38.0% 3M: +29.5% YTD: -15.5% 1Y: -8.8% 3Y: -13.7% 5Y: -36.0%
$6.54
+0.01 (+0.15%)
 
Weekly Expected Move ±28.2%
$3 $5 $7 $8 $10
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 62 · $245.3M mcap · 34M float · 0.694% daily turnover · Short 27% of daily vol

📊 Key Metrics

TTM
$125M
Revenue
-4.1% YoY
$-32M
Net Income
+27.7% YoY
$4M
Free Cash Flow
+138.2% YoY
35.3%
Gross Margin
7.5%
Op. Margin
-18.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE202.6%
ROA-13.8%
ROIC0.1%

Valuation

P/E-5.9
P/B15.3
EV/EBITDA-171.8

Leverage

Debt/Equity-4.55
Current Ratio3.87
Interest Cov.-0.4x

Quality Scores

Piotroski F5/9
Altman Z-0.33
Beneish M-2.51

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms